MyFinsight
Home
Blog
About
Contact
Download
Download image
Total comprehensive
loss
-$84,900K
(-54.13%↓ Y/Y)
Net loss
-$79,118K
(3.63%↑ Y/Y)
Total other
comprehensive (loss) income,...
-$5,782K
Unrealized holding gains on
available-for-sale debt...
$86K
Net loss before
income tax
-$78,586K
(4.25%↑ Y/Y)
Income tax expenses
$532K
(2318.18%↑ Y/Y)
Foreign currency
exchange translation...
-$5,868K
(-121.73%↓ Y/Y)
Product
$21,144K
License
$50K
Loss from operations
-$71,621K
(-5.52%↓ Y/Y)
Total other
(expenses) income, net
-$6,965K
(50.94%↑ Y/Y)
Total revenue
$21,194K
Interest income
$4,382K
(-47.33%↓ Y/Y)
Other income, net
$84K
(55.56%↑ Y/Y)
Selling, general and
administrative expenses
$36,280K
Cost of sales
$28,643K
Research and development
expenses, net
$27,892K
(-30.83%↓ Y/Y)
Interest expense, net
$10,520K
(-1.55%↓ Y/Y)
Foreign exchange
(losses) gains, net
-$911K
(92.33%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Autolus Therapeutics plc (AUTL)
Autolus Therapeutics plc (AUTL)